Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/45003 
Full metadata record
DC FieldValueLanguage
dc.contributor.authorConlé, Marcusen
dc.date.accessioned2010-11-25-
dc.date.accessioned2011-04-19T12:34:17Z-
dc.date.available2011-04-19T12:34:17Z-
dc.date.issued2010-
dc.identifier.urihttp://hdl.handle.net/10419/45003-
dc.description.abstractBiotechnology is one of the knowledge fields particularly targeted by China, as it is considered to open up windows of opportunity for catch-up to the leading economies. However, the seizing of these opportunities requires the existence of an institutional and organizational structure supportive of the introduction and usage of biotechnological knowledge. The present contribution discusses this problem in its national, regional, and sectoral dimensions. By focusing on the biopharmaceutical sector, it is shown that the regulatory environment and the capital market constitute serious bottlenecks to further development.en
dc.language.isoengen
dc.publisher|aUniversity of Duisburg-Essen, Institute of East Asian Studies (IN-EAST) |cDuisburgen
dc.relation.ispartofseries|aDuisburg Working Papers on East Asian Studies |x87/2010en
dc.subject.ddc330en
dc.subject.keywordChinaen
dc.subject.keywordhealth biotechnologyen
dc.subject.keywordinnovation systemen
dc.subject.keywordpharmaceuticalen
dc.titleHealth biotechnology in China: National, regional, and sectoral dimensions-
dc.typeWorking Paperen
dc.identifier.ppn640609481en
dc.rightshttp://www.econstor.eu/dspace/Nutzungsbedingungenen
dc.identifier.repecRePEc:zbw:udedao:872010en

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.